Source

US Federal Register - DEA Telehealth Rules

US Federal Register - DEA Telehealth Rules is an official public source that HealthSignal monitors for Digital Health & AI, General Regulatory. The most recent updates we have tracked from it are listed below, each normalised into our index and linked back to the original publication on the source's own website.

Regulation Category Impact Date

Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment

The "Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 (the SUPPORT Act)," which became law on October 24, 2018, amended the Controlled Substances A...

US Federal Register - DEA Telehealth Rules
PharmaceuticalsGeneral Regulatory
High

Expansion of Buprenorphine Treatment via Telemedicine Encounter

The Drug Enforcement Administration and the Department of Health and Human Services are amending their regulations to expand the circumstances under which practitioners registered by the Drug Enforcement Administratio...

US Federal Register - DEA Telehealth Rules
PharmaceuticalsGeneral Regulatory
High

Continuity of Care via Telemedicine for Veterans Affairs Patients

This final rule authorizes Department of Veterans Affairs (VA) practitioners acting within the scope of their VA employment to prescribe controlled substances via telemedicine to a VA patient with whom they have not c...

US Federal Register - DEA Telehealth Rules
Digital Health & AIPharmaceuticals
High

Expansion of Induction of Buprenorphine via Telemedicine Encounter

The Drug Enforcement Administration (DEA) is amending its regulations, in concert with the Department of Health and Human Services (HHS), to expand the circumstances under which individual practitioners are authorized...

US Federal Register - DEA Telehealth Rules
General RegulatoryPharmaceuticals
Medium

Schedules of Controlled Substances; Exempted Prescription Products

The Drug Enforcement Administration proposes to revoke the exempted prescription product status for all butalbital products previously granted exemptions. Upon publication of a final rule, these products shall become ...

US Federal Register - DEA Telehealth Rules
General RegulatoryPharmaceuticals
Medium
Showing 18 of 18 tracked updates